What is so bad about reverse epidemiology anyway?

Seminars in Dialysis

Volumn 20, Issue 6, 2007, Pages 593-601

  Kalantar Zadeh, Kamyar ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; EPIDEMIOLOGY; HUMAN; MORTALITY; OBESITY; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SURVIVAL RATE;

CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC FACTORS; HUMANS; KIDNEY FAILURE, CHRONIC; MODELS, BIOLOGICAL; OBESITY; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE;

EID: 35948957875     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00360.x     Document Type: Review

References (113)

1. Futterman LG, Lemberg L : The Framingham Heart Study: a pivotal legacy of the last millennium. Am J Crit Care 9 : 147 151, 2000
2. Dawber TR, Meadors GF, Moore Jr. FE : Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 41 : 279 281, 1951
3. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW : Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. Jama 290 : 891 897, 2003
4. Stein JH, McBride PE : Benefits of cholesterol screening and therapy for primary prevention of cardiovascular disease: a new paradigm. J Am Board Fam Pract 11 : 72 77, 1998
5. Rothman KJ, Greenland S : Causation and causal inference in epidemiology. Am J Public Health 95 (Suppl. 1 S144 S150, 2005
6. Hill AB : The environment and disease: association or causation? Proc R Soc Med 58 : 295 300, 1965
7. Greenland S, Brumback B : An overview of relations among causal modelling methods. Int J Epidemiol 31 : 1030 1037, 2002
8. Maldonado G, Greenland S : Estimating causal effects. Int J Epidemiol 31 : 422 429, 2002
9. Hernán MA, Brumback BA, Robins JM : Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Stat Med 21 : 1689 1709, 2002
10. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR : Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 : 1557 1565, 2002
11. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E : C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 : 20 28, 2005
12. de Lorgeril M, Salen P : Cholesterol lowering and mortality: time for a new paradigm? Nutr Metab Cardiovasc Dis 16 : 387 390, 2006
13. Vlagopoulos PT, Sarnak MJ : Traditional and nontraditional cardiovascular risk factors in chronic kidney disease. Med Clin North Am 89 : 587 611, 2005
14. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E : Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 : 238 248, 2005
15. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD : Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63 : 793 808, 2003
16. Kopple JD : The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. Am J Clin Nutr 81 : 1257 1266, 2005
17. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, Greenland S : Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 46 : 489 500, 2005
18. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD : Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension 45 : 811 817, 2005
19. Nishizawa Y, Shoji T, Ishimura E, Inaba M, Morii H : Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis 38 (4 Suppl. 1 S4 S7, 2001
20. Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD : A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 15 : 442 453, 2004
21. Lowrie EG, Lew NL : Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15 : 458 482, 1990
22. Kalantar-Zadeh K, Kuwae N, Wu DY, Shantouf RS, Fouque D, Anker SD, Block G, Kopple JD : Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83 : 202 210, 2006
23. Fleischmann EH, Bower JD, Salahudeen AK : Risk factor paradox in hemodialysis: better nutrition as a partial explanation. ASAIO J 47 : 74 81, 2001
24. Kalantar-Zadeh K, Kopple JD : Obesity paradox in patients on maintenance dialysis. Contrib Nephrol 151 : 57 69, 2006
25. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, Wu DY : Reverse epidemiology: a spurious hypothesis or a hardcore reality? Blood Purif 23 : 57 63, 2005
26. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC : Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43 : 1439 1444, 2004
27. Escalante A, Haas RW, del Rincon I : Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 165 : 1624 1629, 2005
28. Chao FC, Efron B, Wolf P : The possible prognostic usefulness of assessing serum proteins and cholesterol in malignancy. Cancer 35 : 1223 1229, 1975
29. Halabi S, Small EJ, Vogelzang NJ : Elevated body mass index predicts for longer overall survival duration in men with metastatic hormone-refractory prostate cancer. J Clin Oncol 23 : 2434 2435, 2005 author reply 2435.
30. Roubenoff R : Acquired immunodeficiency syndrome wasting, functional performance, and quality of life. Am J Manag Care 6 : 1003 1016, 2000
31. Chlebowski RT, Grosvenor M, Lillington L, Sayre J, Beall G : Dietary intake and counseling, weight maintenance, and the course of HIV infection. J Am Diet Assoc 95 : 428 432, 1995 quiz 433-425.
32. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sorensen TI, Lange P : Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 173 : 79 83, 2006
33. Oreopoulos A, Padwal R, Norris C, Mullen JC, Kalantar-Zadeh K : The relationship between different degrees of obesity and short and long-term mortality post-coronary revascularization: a meta-analysis Obesity (Silver Spring). 2007 (in press)
34. Kovesdy CP, Anderson JE, Kalantar-Zadeh K : Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 49 : 581 591, 2007
35. Kovesdy CP, Anderson JE, Kalantar-Zadeh K : Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome. J Am Soc Nephrol 18 : 304 311, 2007
36. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE : Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant 21 : 1257 1262, 2006
37. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL : The effect of age on the association between body-mass index and mortality. N Engl J Med 338 : 1 7, 1998
38. Yeh S, Wu SY, Levine DM, Parker TS, Olson JS, Stevens MR, Schuster MW : Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome. J Nutr Health Aging 4 : 246 251, 2000
39. Lew SQ, Cohn F, Cohen LM, Kimmel PL : Ethical issues in aging and renal disease. Adv Ren Replace Ther 7 : 63 69, 2000
40. Gruberg L, Mercado N, Milo S, Boersma E, Disco C, van Es GA, Lemos PA, Ben Tzvi M, Wijns W, et al. : Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II? Am J Cardiol 95 : 439 444, 2005
41. Grabowski DC, Ellis JE : High body mass index does not predict mortality in older people: analysis of the Longitudinal Study of Aging. J Am Geriatr Soc 49 : 968 979, 2001
42. Landi F, Onder G, Gambassi G, Pedone C, Carbonin P, Bernabei R : Body mass index and mortality among hospitalized patients. Arch Intern Med 160 : 2641 2644, 2000
43. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB : Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81 : 543 554, 2005
44. Kalantar-Zadeh K : Causes and consequences of the reverse epidemiology of body mass index in dialysis patients. J Ren Nutr 15 : 142 147, 2005
45. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH : The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38 : 789 795, 2001
46. Schrier RW, Abraham WT : Hormones and hemodynamics in heart failure. N Engl J Med 341 : 577 585, 1999
47. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW : Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 277 : E971 E975, 1999
48. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD : Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353 : 1838 1842, 1999
49. Rauchhaus M, Coats AJ, Anker SD : The endotoxin-lipoprotein hypothesis. Lancet 356 : 930 933, 2000
50. Rauchhaus M, Koloczek V, Volk H, Kemp M, Niebauer J, Francis DP, Coats AJ, Anker SD : Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol 76 : 125 133, 2000
51. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE : Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7 : 728 736, 1996
52. Kaysen GA, Rathore V, Shearer GC, Depner TA : Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 48 : 510 516, 1995
53. Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, Himmelfarb J : Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis 42 : 286 294, 2003
54. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S : Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 20 : 1880 1888, 2005
55. Sarkar SR, Kuhlmann MK, Kotanko P, Zhu F, Heymsfield SB, Wang J, Meisels IS, Gotch FA, Kaysen GA, et al. : Metabolic consequences of body size and body composition in hemodialysis patients. Kidney Int 70 : 1832 1839, 2006
56. Byers T : Body weight and mortality. N Engl J Med 333 : 723 724, 1995
57. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE : Body weight and mortality among women. N Engl J Med 333 : 677 685, 1995
58. Lew EA, Garfinkel L : Variations in mortality by weight among 750,000 men and women. J Chronic Dis 32 : 563 576, 1979
59. Macdonald FC : Quetelet index as indicator of obesity. Lancet 1 : 1043, 1986
60. Kushner RF : Body weight and mortality. Nutr Rev 51 : 127 136, 1993
61. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, Levine DM : Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 328 : 313 318, 1993
62. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL : Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161 : 1413 1419, 2001
63. Combating undernutrition in the Third World. Lancet 1 : 334 336, 1988
64. Collins S, Myatt M : Short-term prognosis in severe adult and adolescent malnutrition during famine: use of a simple prognostic model based on counting clinical signs. Jama 284 : 621 626, 2000
65. Salama P, Assefa F, Talley L, Spiegel P, van Der Veen A, Gotway CA : Malnutrition, measles, mortality, and the humanitarian response during a famine in Ehiopia. Jama 286 : 563 571, 2001
66. Foley RN, Parfrey PS, Sarnak MJ : Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9 (12 Suppl. S16 S23, 1998
67. Foley RN, Parfrey PS, Sarnak MJ : Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 (5 Suppl. 3 S112 S119, 1998
68. Chertow GM, Paltiel AD, Owen Jr. WF, Lazarus JM : Cost-effectiveness of cancer screening in end-stage renal disease. Arch Intern Med 156 : 1345 1350, 1996
69. Lev-Ran A : Human obesity: an evolutionary approach to understanding our bulging waistline. Diabetes Metab Res Rev 17 : 347 362, 2001
70. Schold JD, Srinivas TR, Guerra G, Reed AI, Johnson RJ, Weiner ID, Oberbauer R, Harman JS, Hemming AW, et al. : A 'weight-listing' paradox for candidates of renal transplantation? Am J Transplant 7 : 550 559, 2007.
71. Kalantar-Zadeh K, Abbott KC, Kronenberg F, Anker SD, Horwich TB, Fonarow GC : Epidemiology of dialysis patients and heart failure patients. Semin Nephrol 26 : 118 133, 2006
72. National Kidney Foundation I, Kidney-Dialysis Outcome Quality Initiative. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45 (Suppl. 3 2005
73. Kalantar-Zadeh K, Braglia A, Chow J, Kwon O, Kuwae N, Colman S, Cockram DB, Kopple JD : An anti-inflammatory and antioxidant nutritional supplement for hypoalbuminemic hemodialysis patients: a pilot/feasibility study. J Ren Nutr 15 : 318 331, 2005
74. Rammohan M, Kalantar-Zadeh K, Liang A, Ghossein C : Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. J Ren Nutr 15 : 345 355, 2005
75. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD : Appetite and inflammation, nutrition, anemia and clinical outcome in hemodialysis patients. Am J Clin Nutr 80 : 299 307, 2004
76. Colman S, Bross R, Benner D, Chow J, Braglia A, Arzaghi J, Dennis J, Martinez L, Baldo DB, et al. : The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: overview of the NIED study and the role of dietitians. J Ren Nutr 15 : 231 243, 2005
77. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP, Younessi H, Anker SD, Morley JE : Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 10 : 433 442, 2007
78. Levin NW, Handelman GJ, Coresh J, Port FK, Kaysen GA : Reverse epidemiology: a confusing, confounding and inaccurate term. Semin Dial (in press)
79. McClellan WM, Chertow GM : Beyond framingham: cardiovascular risk profiling in ESRD. J Am Soc Nephrol 16 : 1539 1541, 2005
80. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, et al. : Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364 : 685 696, 2004
81. Swaminathan B : The potential for linking clinical isolates to food isolates from routine surveillance samples and the epidemiological implications. http://ift.confex.com/ift/2003/techprogram/paper_16477.htm. Chicago, IL : Foodborne & Diarrheal Diseases Branch, Centers for Disease Control & Prevention, Div. of Bacterial & Mycotic Diseases, Atlanta, GA.
82. Testimony on National Cancer Institute's FY 1998 Budget by Richard D. Klausner, M.D., Director of the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Before the House Appropriations Committee, Subcommittee on Labor, Health and Human Services, Education and Related Agencies. http://www.hhs.gov/asl/testify/b970226b.html, 1997
83. Foley RN : Cardiac disease in chronic uremia: can it explain the reverse epidemiology of hypertension and survival in dialysis patients? Semin Dial 17 : 275 278, 2004
84. Tronche F, Casanova E, Turiault M, Sahly I, Kellendonk C : When reverse genetics meets physiology: the use of site-specific recombinases in mice. FEBS Lett 529 : 116 121, 2002
85. Sakurai T : Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology. Regul Pept 126 : 3 10, 2005
86. Birgul N, Weise C, Kreienkamp HJ, Richter D : Reverse physiology in drosophila: identification of a novel allatostatin-like neuropeptide and its cognate receptor structurally related to the mammalian somatostatin/galanin/ opioid receptor family. EMBO J 18 : 5892 5900, 1999
87. Plutzky J : Medicine. PPARs as therapeutic targets: reverse cardiology? Science 302 : 406 407, 2003
88. Kliewer SA, Lehmann JM, Willson TM : Orphan nuclear receptors: shifting endocrinology into reverse. Science 284 : 757 760, 1999
89. Viatte S, Alves PM, Romero P : Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles. Immunol Cell Biol 84 : 318 330, 2006
90. Rathmann W, Herder C : Adiponectin and cardiovascular mortality: evidence for "reverse epidemiology". Horm Metab Res 39 : 1 2, 2007
91. Pliakogiannis T, Trpeski L, Taskapan H, Shah H, Ahmad M, Fenton S, Bargman J, Oreopoulos D : Reverse epidemiology in peritoneal dialysis patients: the Canadian experience and review of the literature. Int Urol Nephrol 39 : 281 288, 2007
92. Movilli E : Homocysteine and reverse epidemiology. Nephrol Dial Transplant 22 : 2093, 2007
93. Dieperink H : Reverse epidemiology in dialysis patients. The Danish Society of Nephrology. Ugeskr Laeger 169 : 1122, 2007
94. van der Sande FM, Koorman JP, Leunissen KM : Reverse epidemiology of blood pressure in dialysis patients: implications for treatment? Neth J Med 63 : 373 375, 2005
95. Nurmohamed SA, Nube MJ : Reverse epidemiology: paradoxical observations in haemodialysis patients. Neth J Med 63 : 376 381, 2005
96. Lavie CJ, Mehra MR, Milani RV : Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J 26 : 5 7, 2005
97. Borsboom H, Smans L, Cramer MJ, Kelder JC, Kooistra MP, Vos PF, van Jaarsveld BC : Long-term blood pressure monitoring and echocardiographic findings in patients with end-stage renal disease: reverse epidemiology explained? Neth J Med 63 : 399 406, 2005
98. Essential Science Indicators. Emerging Research Fronts in Feb 2006 (http://www.esi-topics.com/erf/february2006.html), Thomson Scientific Solutions, 2006
99. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ : Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. Jama 291 : 451 459, 2004
100. Kalantar-Zadeh K, Anker SD : Inflammation, cholesterol levels, and risk of mortality among patients receiving dialysis. Jama 291 : 1834, 2004 author reply 1834-1835.
101. McAuley P, Myers J, Abella J, Froelicher V : Body mass, fitness and survival in veteran patients: another obesity paradox? Am J Med 120 : 518 524, 2007
102. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M : An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153 : 74 81, 2007
103. Artham SM, Lavie CJ, Milani RV, Ventura HO : The obesity paradox and discrepancy between peak oxygen consumption and heart failure prognosis-it's all in the fat. Congest Heart Fail 13 : 177 180, 2007
104. Habbu A, Lakkis NM, Dokainish H : The obesity paradox: fact or fiction? Am J Cardiol 98 : 944 948, 2006
105. Diercks DB, Roe MT, Mulgund J, Pollack Jr. CV, Kirk JD, Gibler WB, Ohman EM, Smith Jr. SC, Boden WE, et al. : The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J 152 : 140 148, 2006
106. Tanko LB, Christiansen C : Can the obesity paradox be explained by the protective effects of peripheral adiposity? Arch Intern Med 165 : 1796 1797, 2005 author reply 1797-1798.
107. Kalantar-Zadeh K, Balakrishnan VS : The kidney disease wasting: Inflammation, oxidative stress, and diet-gene interaction. Hemodial Int 10 : 315 325, 2006
108. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr. CW : Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341 : 1097 1105, 1999
109. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW : Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 16 : 2386 2394, 2001
110. Kurakin A : Watchmaker versus Self-Organization. Part I. Critique of The Newtonian Worldview. http://www.alexeikurakin.org/main/lecture6Ext.html, Novato Lectures at http://www.alexeikurakin.org, 2007
111. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK : Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 35 : 80 88, 2000
112. Kopple JD, Zhu X, Lew NL, Lowrie EG : Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 56 : 1136 1148, 1999
113. Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimburger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, et al. : Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 65 : 274 281, 2004